Australia’s Health Minister Greg Hunt in charge of rolling out Australia’s coronavirus vaccine program has been hospitalized just one day after taking the AstraZeneca COVID-19 vaccine.
- EXPLOSIVE: Here’s what was uncovered in Hunter Biden’s iCloud Hack
- MAJOR PEER REVIEWED STUDY: Moderna Vaccine Increases Myocarditis Risk By 44 Times In Young Adults
- MUST READ: High Level International Bankers Simulate The Collapse Of Global Financial System
- BIG STORY: Wuhan Lab Isolated Monkeypox Strain In 2020
- EXPLOSIVE: Ukraine Biolabs Used Fever Carrying Mosquitoes To Spark Dengue Pandemic In Cuba
Greg Hunt’s office on Tuesday night revealed the minister had been admitted to hospital with a suspected infection and was “being kept overnight for observation and is being administered antibiotics and fluid”.
“The minister is expected to make a full recovery,” a spokesperson said in a statement. “His condition is not considered to be related to the vaccine.”
The previous day, Hunt said on Twitter that he had been inoculated at the weekend with AstraZeneca Plc’s COVID-19 vaccine, one of two being distributed in the country.
Hunt received his first dose of the AstraZeneca vaccine on Sunday.
Subscribe to GreatGameIndia
Earlier, the Australian Government scrapped a billion dollar coronavirus vaccine agreement with Australian biotech company CSL Limited to supply 51 million doses of a Covid-19 vaccine being developed by the University of Queensland after several trial participants returned false positive HIV test results.
Meanwhile, Austrian authorities have discontinued use of AstraZeneca’s vaccine after the illness of one person and death of another were reported after getting vaccinated for COVID-19.
Even, France is planning to slow down its vaccine rollout after its hospital staff were unable to work due to numerous side-effects from the COVID-19 vaccine. Hospitals in different parts of the country are facing shortage of staff too because half of the workers are on sick leave after getting vaccinated.
South Africa also stopped the AstraZeneca Oxford COVID-19 vaccine program after disappointing results from trial data showed it gave minimal protection against mild to moderate infection caused by the country’s dominant coronavirus variant.
For latest updates on the outbreak check out our Coronavirus Coverage.